首页> 美国卫生研究院文献>Vascular Health and Risk Management >Review and recommendations on management of refractory raised intracranial pressure in aneurysmal subarachnoid hemorrhage
【2h】

Review and recommendations on management of refractory raised intracranial pressure in aneurysmal subarachnoid hemorrhage

机译:动脉瘤性蛛网膜下腔出血难治性颅内压升高的回顾及建议

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Intracranial hypertension is commonly encountered in poor-grade aneurysmal subarachnoid hemorrhage patients. Refractory raised intracranial pressure is associated with poor prognosis. The management of raised intracranial pressure is commonly referenced to experiences in traumatic brain injury. However, pathophysiologically, aneurysmal subarachnoid hemorrhage is different from traumatic brain injury. Currently, there is a paucity of consensus on the management of refractory raised intracranial pressure in spontaneous subarachnoid hemorrhage. We discuss in this paper the role of hyperosmolar agents, hypothermia, barbiturates, and decompressive craniectomy in managing raised intracranial pressure refractory to first-line treatment, in which preliminary data supported the use of hypertonic saline and secondary decompressive craniectomy. Future clinical trials should be carried out to delineate better their roles in management of raised intracranial pressure in aneurysmal subarachnoid hemorrhage patients.
机译:颅内高压常见于不良级别的动脉瘤性蛛网膜下腔出血患者。难治性颅内压升高与预后不良有关。颅内压升高的处理通常参考颅脑外伤的经验。但是,从病理生理上讲,动脉瘤性蛛网膜下腔出血不同于颅脑外伤。目前,对于自发性蛛网膜下腔出血难治性颅内压升高的处理尚缺乏共识。我们在本文中讨论高渗药物,体温过低,巴比妥类药物和减压颅骨切除术在处理颅内压升高至一线治疗难治性疾病中的作用,其中初步数据支持高渗盐水和继发减压颅骨切除术的使用。将来应进行临床试验,以更好地描述其在动脉瘤性蛛网膜下腔出血患者颅内压升高的管理中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号